| CDK8 is a colorectal cancer oncogene that regulates β-catenin activity R Firestein, AJ Bass, SY Kim, IF Dunn, SJ Silver, I Guney, E Freed, ... Nature 455 (7212), 547-551, 2008 | 795 | 2008 |
| Circular RNAs: biogenesis, function and role in human diseases J Greene, AM Baird, L Brady, M Lim, SG Gray, R McDermott, SP Finn Frontiers in molecular biosciences 4, 38, 2017 | 503 | 2017 |
| Gleason score and lethal prostate cancer: does 3+ 4= 4+ 3? JR Stark, S Perner, MJ Stampfer, JA Sinnott, S Finn, AS Eisenstein, J Ma, ... Journal of Clinical Oncology 27 (21), 3459, 2009 | 457 | 2009 |
| Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer T Migita, S Ruiz, A Fornari, M Fiorentino, C Priolo, G Zadra, F Inazuka, ... Journal of the National Cancer Institute 101 (7), 519-532, 2009 | 435 | 2009 |
| Potential role of miR-9 and miR-223 in recurrent ovarian cancer A Laios, S O'Toole, R Flavin, C Martin, L Kelly, M Ring, SP Finn, C Barrett, ... Molecular cancer 7, 1-14, 2008 | 385 | 2008 |
| Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN I Vivanco, N Palaskas, C Tran, SP Finn, G Getz, NJ Kennedy, J Jiao, ... Cancer cell 11 (6), 555-569, 2007 | 282 | 2007 |
| Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy J Du, P Bernasconi, KR Clauser, DR Mani, SP Finn, R Beroukhim, ... Nature biotechnology 27 (1), 77-83, 2009 | 256 | 2009 |
| Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells K Egan, D Crowley, P Smyth, S O'Toole, C Spillane, C Martin, ... PloS one 6 (10), e26125, 2011 | 218 | 2011 |
| B-RafV600E and thrombospondin-1 promote thyroid cancer progression C Nucera, A Porrello, ZA Antonello, M Mekel, MA Nehs, TJ Giordano, ... Proceedings of the National Academy of Sciences 107 (23), 10649-10654, 2010 | 202 | 2010 |
| B-RafV600E and thrombospondin-1 promote thyroid cancer progression C Nucera, A Porrello, ZA Antonello, M Mekel, MA Nehs, TJ Giordano, ... Proceedings of the National Academy of Sciences 107 (23), 10649-10654, 2010 | 202 | 2010 |
| A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer TU Ahearn, A Pettersson, EM Ebot, T Gerke, RE Graff, CL Morais, ... Journal of the National Cancer Institute 108 (2), djv346, 2016 | 201 | 2016 |
| Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways G Leon, L MacDonagh, SP Finn, S Cuffe, MP Barr Pharmacology & therapeutics 158, 71-90, 2016 | 191 | 2016 |
| Long non-coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells R Heery, SP Finn, S Cuffe, SG Gray Cancers 9 (4), 38, 2017 | 181 | 2017 |
| The isopeptidase USP2a protects human prostate cancer from apoptosis C Priolo, D Tang, M Brahamandan, B Benassi, E Sicinska, S Ogino, ... Cancer research 66 (17), 8625-8632, 2006 | 174 | 2006 |
| mRNA expression signature of Gleason grade predicts lethal prostate cancer KL Penney, JA Sinnott, K Fall, Y Pawitan, Y Hoshida, P Kraft, JR Stark, ... Journal of Clinical Oncology 29 (17), 2391, 2011 | 166 | 2011 |
| Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel JM Fitzpatrick, J Bellmunt, K Fizazi, A Heidenreich, CN Sternberg, ... European Journal of Cancer 50 (9), 1617-1627, 2014 | 162 | 2014 |
| Lung cancer stem cells: The root of resistance L MacDonagh, SG Gray, E Breen, S Cuffe, SP Finn, KJ O'Byrne, MP Barr Cancer letters 372 (2), 147-156, 2016 | 157 | 2016 |
| The role of DNA repair pathways in cisplatin resistant lung cancer S O’Grady, SP Finn, S Cuffe, DJ Richard, KJ O’Byrne, MP Barr Cancer treatment reviews 40 (10), 1161-1170, 2014 | 155 | 2014 |
| Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer M Fiorentino, G Zadra, E Palescandolo, G Fedele, D Bailey, C Fiore, ... Laboratory investigation 88 (12), 1340-1348, 2008 | 152 | 2008 |
| Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer JL Kasperzyk, SP Finn, R Flavin, M Fiorentino, R Lis, WK Hendrickson, ... Cancer epidemiology, biomarkers & prevention 22 (12), 2354-2363, 2013 | 147 | 2013 |
